337 studies found for:    metabolic syndrome AND syndrome X AND insulin resistance AND diabetes
Show Display Options
Rank Status Study
1 Completed The Metabolic Effects of Different Weight Loss Diets
Conditions: Metabolic Syndrome X;   Obesity;   Insulin Resistance;   Hypertension;   Diabetes
Interventions: Behavioral: The DASH diet;   Behavioral: The low glycemic Index Diet;   Behavioral: Reduced calorie American Diet
2 Unknown  Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study)
Conditions: Healthy;   Metabolic Syndrome X;   Hyperlipidemia;   Hypertension;   Diabetes Mellitus
Intervention:
3 Completed Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome
Conditions: Diabetes Mellitus;   Steroid Diabetes;   Glucocorticoid-induced Diabetes;   Beta-cell Function
Interventions: Drug: Sitagliptin 100 mg;   Drug: Prednisolone 30 mg;   Drug: Sitagliptin-placebo;   Drug: Prednisolone-placebo
4 Completed Genetics of the Metabolic Syndrome in Japanese Americans
Conditions: Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Insulin Resistance;   Diabetes Mellitus, Non-insulin Dependent;   Diabetes Mellitus;   Metabolic Syndrome X
Intervention:
5 Completed Surgical Removal of Visceral Fat Tissue (Omentectomy) Associated to Bariatric Surgery: Effects on Insulin Sensitivity
Conditions: Insulin Resistance;   Obesity;   Metabolic Syndrome X
Interventions: Procedure: Roux-en-Y Gastric Bypass plus total omentectomy;   Procedure: Roux-en-Y Gastric Bypass
6 Active, not recruiting Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation
Conditions: Metabolic Syndrome X;   Prediabetic State
Interventions: Drug: Fenofibrate;   Drug: Pioglitazone and Fenofibrate
7 Completed Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
Conditions: Schizophrenia;   Metabolic Syndrome X;   Insulin Resistance
Interventions: Drug: Ziprasidone;   Drug: Standard atypical antipsychotic drug
8 Terminated Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
Conditions: Psoriasis;   Metabolic Syndrome;   Hyperlipidemia;   Obesity;   Hypertension
Intervention: Drug: Etanercept
9 Suspended Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Diabetes Mellitus, Type 2
Intervention: Drug: topiramate
10 Completed Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity
Conditions: Metabolic Syndrome X;   Liver Diseases
Intervention: Other: diet intervention
11 Completed Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome
Conditions: Metabolic Syndrome;   Impaired Glucose Tolerance;   Insulin Resistance;   Endothelial Dysfunction
Interventions: Drug: L-arginine;   Drug: Placebo
12 Unknown  The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study
Condition: Metabolic Syndrome X
Interventions: Drug: Study drugs: Metformin and fenofibrate;   Drug: Study Drug: Metformin;   Drug: Study Drug: fenofibrate;   Drug: Metformin and Fenofibrate placebo
13 Recruiting Magnesium and Metabolic Syndrome: A Dose-response Meta-analysis
Conditions: Metabolic Syndrome X;   Insulin Resistance Syndrome X;   Metabolic Cardiovascular Syndrome;   Dysmetabolic Syndrome X
Intervention:
14 Active, not recruiting Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Prediabetic State;   Insulin Resistance;   Obesity;   Metabolic Diseases
Interventions: Drug: Dietary supplement for weight loss;   Behavioral: Education and counseling for weight loss
15 Completed Central Obesity and Disease Risk in Japanese Americans
Conditions: Cardiovascular Diseases;   Heart Diseases;   Atherosclerosis;   Hypertension;   Obesity;   Diabetes Mellitus, Non-insulin Dependent;   Hyperinsulinism;   Insulin Resistance;   Coronary Arteriosclerosis;   Diabetes Mellitus;   Metabolic Syndrome X
Intervention:
16 Completed Chromium Picolinate for the Treatment of Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Prediabetic State;   Insulin Resistance;   Obesity;   Metabolic Diseases
Intervention: Drug: Chromium picolinate
17 Recruiting Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
Conditions: Impaired Glucose Tolerance;   Pre-diabetes;   Childhood Obesity;   Insulin Resistance;   Metabolic Syndrome
Intervention:
18 Unknown  Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)
Conditions: Metabolic Syndrome;   Diabetes
Intervention:
19 Completed Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion
Conditions: Insulin Resistance Syndrome X;   Pancreatic Beta Cell Function
Intervention: Drug: N-acetylcysteine, intralipid, heparin
20 Unknown  Frequency of Metabolic Syndrome in Down Syndrome Patients
Conditions: Metabolic Syndrome X;   Down Syndrome
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years